The antiparasitic drug Nitazoxanide enhances the susceptibility of Candida albicans to fluconazole
BMC Microbiology · 17.01.2026 · 26 (1)
DOI: 10.1186/s12866-025-04701-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 17.01.2026. Verfasst von Juan Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Candida albicans, Fluconazole, Thiazoles, Antifungal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province.
Abstract (Originalsprache)
BACKGROUND: Fluconazole (FLC) is a widely used antifungal agent; however, Candida albicans is increasingly developing resistance to it. Given the limited range of available antifungal drugs, there is an immediate requirement for the development of novel approaches to improve FLC efficacy against resistant strains. METHODS: This study investigated the synergistic effects of nitazoxanide (NTZ) and FLC against FLC-resistant C. albicans. Combined antifungal activity was evaluated through in vitro and in vivo experiments, including broth microdilution assays, time-kill assays, and the Galleria mellonella infection model. To explore potential mechanisms, hyphal growth inhibition, intracellular adenosine triphosphate (ATP) levels, reactive oxygen species (ROS) production, expression of resistance-related genes, Rhodamine 6G (Rh6G) efflux, and membrane potential changes were assessed. RESULTS: NTZ combined with FLC exerted a synergistic antifungal effect against FLC-resistant C. albicans. The combination increased ROS production, decreased ATP levels and metabolic capacity, inhibited hyphal growth of C. albicans and biofilm formation, suppressed efflux gene expression, lowered membrane potential, and reduced drug efflux, among others. Moreover, it was confirmed that FLC combined with NTZ not only effectively enhanced the survival rate of G. mellonella infected with C. albicans, but also significantly reduced the colony burden in G. mellonella. CONCLUSIONS: The results in this study provide preliminary experimental evidence supporting the potential clinical application of NTZ combined with FLC. This regimen may improve FLC efficacy and represents an exploratory approach for optimizing antifungal treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Medical Inspection, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou, Zhejiang, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. sunyaowzmu@163.com.
- Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325003, China. sunyaowzmu@163.com.
- Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. wyztli@163.com.
- Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325003, China. wyztli@163.com.
Förderung
- Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province
Zitieren
APA
Pan, J., Yao, Z., Zhang, J., Hu, P., Ye, L., Zhou, B., Shi, S., Sun, Y., & Zhou, T. (2026). The antiparasitic drug Nitazoxanide enhances the susceptibility of Candida albicans to fluconazole. BMC Microbiology, 26(1). https://doi.org/10.1186/s12866-025-04701-1
Vancouver
Pan J, Yao Z, Zhang J, Hu P, Ye L, Zhou B, et al. The antiparasitic drug Nitazoxanide enhances the susceptibility of Candida albicans to fluconazole. BMC Microbiology. 2026;26(1). doi:10.1186/s12866-025-04701-1
BibTeX
@article{Pan2026,
author = {Pan, Juan and Yao, Zhuocheng and Zhang, Jia and Hu, Panjie and Ye, Lulu and Zhou, Beibei and Shi, Shiyi and Sun, Yao and Zhou, Tieli},
title = {The antiparasitic drug Nitazoxanide enhances the susceptibility of Candida albicans to fluconazole},
journal = {BMC Microbiology},
year = {2026},
volume = {26},
number = {1},
doi = {10.1186/s12866-025-04701-1}
}
EUVIMED